CRWEFinance.com Stock Report 11/05/09 KBALB, PWRM
Posted on 11/5/2009 2:27:37 PM in #Stocks | 0 comments comments
CRWEFinance.com Hot Stock News & Alerts!
________________________________________
FREE Daily Stock Alerts From CRWEFinance.com
________________________________________
CRWEFinance.com Stock Report!
********************************************************************************
Kimball International, Inc. (NASDAQ: KBALB) today reported net sales of $274.7 million and net income of $1.8 million, or $0.05 per Class B diluted share, for the first quarter of fiscal year 2010, which ended September 30, 2009. Consolidated Overview
Financial Highlights (Dollars in thousands, Except Per Share Data) |
|
Three Months Ended |
|
|
|
|
|
September 30, 2009 |
|
|
% of Sales |
|
|
September 30, 2008 |
|
|
% of Sales |
|
|
Percent Change |
Net Sales |
|
$274,659 |
|
|
|
|
|
$339,495 |
|
|
|
|
|
(19%) |
Gross Profit |
|
$47,184 |
|
|
17.2 % |
|
|
$58,512 |
|
|
17.2% |
|
|
|
Selling and Administrative Expense |
|
$46,066 |
|
|
16.8% |
|
|
$53,305 |
|
|
15.7% |
|
|
|
Restructuring Expense |
|
$486 |
|
|
0.2% |
|
|
$963 |
|
|
0.3% |
|
|
|
Net Income |
|
$1,774 |
|
|
0.6% |
|
|
$2,184 |
|
|
0.6% |
|
|
(19%) |
Earnings Per Class B Diluted Share |
|
$0.05 |
|
|
|
|
|
$0.06 |
|
|
|
|
|
(17%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income excluding Restructuring Charges |
|
$2,066 |
|
|
0.8% |
|
|
$2,778 |
|
|
0.8% |
|
|
(26%) |
Earnings Per Class B Diluted Share excluding Restructuring Charges |
|
$0.06 |
|
|
|
|
|
$0.08 |
|
|
|
|
|
(25%) |
Power3 Medical (OTCBB: PWRM) is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins. This dynamic team utilizes proteomics in the discovery of protein biomarkers, drug pathways, and mechanisms of disease.
***********Advertisement***********
    
********************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and has received an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news and $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB).
|